Tag Archives: Oren Livnat

H.C. Wainwright Keeps a Buy Rating on Taiwan Liposome Company Ltd (TLC)

In a report released today, Oren Livnat from H.C. Wainwright maintained a Buy rating on Taiwan Liposome Company Ltd (TLC – Research Report), with a price target of $10. The company’s shares closed on Friday at $5.31, close to its

Lipocine (LPCN) Gets a Buy Rating from H.C. Wainwright

H.C. Wainwright analyst Oren Livnat reiterated a Buy rating on Lipocine (LPCN – Research Report) today and set a price target of $5. The company’s shares closed yesterday at $1.93. Livnat noted: “Valuation and risk. Our $5 target includes $3/share

Jazz Pharmaceuticals (JAZZ) Receives a Hold from H.C. Wainwright

H.C. Wainwright analyst Oren Livnat reiterated a Hold rating on Jazz Pharmaceuticals (JAZZ – Research Report) today and set a price target of $153. The company’s shares closed yesterday at $139.88. Livnat noted: “We’ve long highlighted how conservative EPS guidance

H.C. Wainwright Reiterates Their Buy Rating on Antares Pharma (ATRS)

In a report released today, Oren Livnat from H.C. Wainwright reiterated a Buy rating on Antares Pharma (ATRS – Research Report), with a price target of $4.50. The company’s shares closed on Friday at $3.04. Livnat said: “We’re encouraged to

Analysts Are Bullish on These Healthcare Stocks: Taiwan Liposome Company Ltd (TLC), Mustang Bio Inc (MBIO)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Taiwan Liposome Company Ltd (TLC – Research Report) and Mustang Bio Inc (MBIO – Research Report) with bullish sentiments. Taiwan Liposome Company

BioDelivery (BDSI) Receives a Buy from H.C. Wainwright

H.C. Wainwright analyst Oren Livnat maintained a Buy rating on BioDelivery (BDSI – Research Report) today and set a price target of $6. The company’s shares closed yesterday at $4.62. Livnat noted: “Our $6 12-month target (from $5) is based